...
首页> 外文期刊>Viruses >How HIV-1 Integrase Associates with Human Mitochondrial Lysyl-tRNA Synthetase
【24h】

How HIV-1 Integrase Associates with Human Mitochondrial Lysyl-tRNA Synthetase

机译:HIV-1整合酶如何与人体线粒体溶酶-TRNA合成酶联系起合

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Replication of human immunodeficiency virus type 1 (HIV-1) requires the packaging of tRNA Lys,3 from the host cell into the new viral particles. The GagPol viral polyprotein precursor associates with mitochondrial lysyl-tRNA synthetase (mLysRS) in a complex with tRNA Lys , an essential step to initiate reverse transcription in the virions. The C-terminal integrase moiety of GagPol is essential for its association with mLysRS. We show that integrases from HIV-1 and HIV-2 bind mLysRS with the same efficiency. In this work, we have undertaken to probe the three-dimensional (3D) architecture of the complex of integrase with mLysRS. We first established that the C-terminal domain (CTD) of integrase is the major interacting domain with mLysRS. Using the p Bpa-photo crosslinking approach, inter-protein cross-links were observed involving amino acid residues located at the surface of the catalytic domain of mLysRS and of the CTD of integrase. In parallel, using molecular docking simulation, a single structural model of complex was found to outscore other alternative conformations. Consistent with crosslinking experiments, this structural model was further probed experimentally. Five compensatory mutations in the two partners were successfully designed which supports the validity of the model. The complex highlights that binding of integrase could stabilize the tRNA Lys :mLysRS interaction.
机译:人体免疫缺陷病毒类型1(HIV-1)的复制需要将TrNA Lys的包装从宿主细胞中封装到新的病毒颗粒中。 Gagpol病毒聚丙烯前体与用TRNA Lys中的复合物中的线粒体溶解 - TRNA合成酶(MLYSRS)缔合,这是在病毒粒中引发逆转录的基本步骤。 Gagpol的C末端整体酶部分对于其与Mlysrs的关系至关重要。我们展示了HIV-1和HIV-2的积分酶,具有相同的效率。在这项工作中,我们已经承诺探讨与Mlysrs的整体酶复合物的三维(3D)架构。我们首先确定整合酶的C末端结构域(CTD)是具有MLYSR的主要相互作用域。使用P BPA-光交联方法,观察蛋白质交联酰基群,涉及位于Mlysrs的催化结构域的表面和整体酶的CTD的氨基酸残基。并行地,使用分子对接模拟,发现复合物的单一结构模型来超越其他替代构象。与交联实验一致,通过实验进一步探测该结构模型。两位合作伙伴中的五种补偿性突变成功设计,支持模型的有效性。整体酶结合可以稳定TRNA液体的复合亮点:MLYSRS相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号